





  “Smart” was added to smartphones in the early twenty first century and since then it has changed 
the way we live. Complex mobile applications, fondly known has apps, have altered the way we travel, 
bank, communicate and it is inexplicably going to change the way we manage our health. Smartphone 
technology provides promising ways for us to have more affordable and effective healthcare. The 
mobile health app (mHealth app) landscape is rich with apps eager to address healthcare needs for 
patients and providers. While most health and fitness apps function primarily to instruct or inform users 
and/or record their health information, they are projected to expand into more clinically focused 
functions (e.g., counseling, diagnosing). The Food and Drug Administration (FDA), which currently 
regulates a small group of mHealth apps considered more risky to the public, must correspondingly 
evolve new regulations to deal with the changing mHealth app functionalities. These functionalities may 
include apps that help a patient self-manage disease or conditions such as diabetes, high blood pressure 
and obesity. Current FDA regulations, which exempt certain mHealth apps from regulatory oversight, 
are not enough to deal with future projected growth of mHealth apps. As the volume and functionalities 
of mHealth apps on the market increase, they introduce technical, data privacy, efficacy, legality and 
scope of practice issues.  
 
The aims of this paper are to: 
 Describe the current climate of mHealth apps and its future trajectory; 
 Discuss the gaps in mHealth app regulation; 
 Explore the issues faced by various stakeholders;  
 Provide basic recommendations for stakeholders to make mHealth apps safe and effective tools 
for patients and providers. 
 
 
II. Background: Smartphone Technology Penetrating the Healthcare Field 
 
Mobile phone and smartphone technology is widely adopted by the global community and will 
continue to grow. To date, there are seven billion people worldwide and six billion mobile phone 
subscriptions [1] showing that mobile technology is reaching saturation point in the market. While 
mobile phones have the limited capacity to purely communicate (e.g., phone calls and text messages), 
smartphones are a specialized mobile phone capable of being a miniature computer. The smartphone era 
began in 2002 with personal data assistants (PDAs) introduced by IBM Corporation but this technology 
did not take off until 2006 when Apple introduced its first iPhone. A 2013 Nielsen Report estimate 40% 
of the U.S. population has a smartphone. This figure, which began at 5%, rose to 40% in the span of four 
short years making it one of the quickest adopted technologies in human history [1].  
 
The current smartphone capacity and complexity makes it useful beyond communication: 
Smartphones provide Internet access and geo-positioning and can serve as a high quality camera and 
recording device. Platforms like iOS and Android enables access to rich and complex mobile 
applications (apps) targeting varied user needs—finance, entertainment, news, health and fitness, and so 
forth [2]. Apps that address health and wellness are known as “mobile health apps (mHealth apps)” and 
they are poised to commercialize and monetize in the near future. Research2Guidance, a market research 
company focusing on the global app economy, found market revenue for mHealth apps was US$2.4B in 




Because of the smartphone’s rapid penetration into the U.S. market, there is great “app-ertunity” 
for this technology to symbiotically collaborate with another giant industry: healthcare. 
Research2Guidance estimates that 500 million smartphone users worldwide will be using a healthcare 
app by 2015 and by 2018, more than 3.4 billion smartphone users will have downloaded a mhealth app 
[3]. Technology bears blame for increasing America’s rising healthcare costs but it can also mitigate that 
through promising approaches like electronic health records, telemedicine, telehealth and mHealth apps.  
 
 
III. Current Landscape of mHealth Apps: From the perspective of healthcare providers 
 
The IMS Institute for Healthcare Informatics’ 2013 report “Patient Apps for Improved 
Healthcare” provides a good backdrop to help us understand the mHealth app landscape from the 
perspective of healthcare providers. This report was published as recently as October 2013 and included 
an analysis of health apps by the IMS Health Team comprised of medical collaborators. They analyzed 
43,689 apps in the “Health & Fitness” category of Apple’s App store and excluded 20,007 apps because 
these were considered gimmicks with no health benefits [4]. Only 23,682 mHealth apps were deemed 
beneficial and of these 7,407 were directed at healthcare professionals while 16,275 were directed at 
users/patients. These mHealth apps were categorized non-exclusively into seven functionality bins: 1) 
informs, 2) instructs, 3) records, 4) displays, 5) guides, 6) reminds/alerts, and 7) communicates. Figure 1 
comes from the IMS Institute of Healthcare Informatics and shows the abundance of apps by 




Figure 1: Functionalities of Consumer-focused mHealth apps 
Source: Created from the IMS Institute for Healthcare Informatics’ 2013 report “Patient Apps for Improved Healthcare.” 
 
Given that mHealth apps revolve around these seven functionalities, the IMS Team believes that the best 
benefit to befall users would logically follow this scenario displayed by Figure 2: 
 
 
 Figure 2: How users benefit from mHealth apps 
















"An analysis of 16, 275 consumer-focused mHealth apps showed 
most apps INFORM, INSTRUCT or RECORD. They have the 
potential to grow in other functionalities." 
Users/patients 
COLLECT data 











As Figure 2 logically points out, these providers want mHealth apps to collect health data that is 
then used to 1) supplement patient-provider interactions, and 2) help patients reach health goals. To 
understand how mHealth cans achieve these, the IMS Health Team classified consumer-focused apps 
based on where they fit on the “patient journey” (see Figure 3). The patient journey is “how patients 
experience a disease or condition from their first awareness of symptoms through all stages of diagnosis 
and treatment; culmination in a cure, 
remission or worsening of the condition” 
[5]. Of the 16,275 mHealth apps, 14,428 
apps were relevantly placed on the 
patient journey [4]. Clearly, the market 
is skewed towards apps focused on 
prevention/healthy lifestyle, which 
coincides with the scope of dietitians and 
is the main focus of this paper.  
 
Dietitians and healthcare 
providers are eager for mHealth apps 
with improve functionalities that can fill 
in the gap of the patient journey, but the 
current landscape is mired with 
obstacles. Existing obstacles blocking 
mHealth apps from maximizing their 
usefulness include a lack of evidence 
proving mHealth app efficacy. 
Moreover, the use of smartphone 
technology is heavily skewed towards 
younger age groups but it is older adults 
that incur more healthcare costs. According to the Pew Research Center, in 2014, 97-98% of adults age 
18-49 years old own smartphones compared to 88% in adults age 50-64 and 74% of adults age 65+ [6].   
Certainly, mHealth apps will not be useful to populations that are technologically illiterate, and even for 
those who are technologically literate and have access to smartphones, navigating mHealth apps is a 
confusing affair. Current app stores are plagued with misclassified and gimmicky (e.g., they do not 
confer medical benefits) apps. App developers, public health leaders and healthcare professionals alike 
must address these obstacles if they want mHealth apps to be a powerful tool in the patient journey. 
 
From the perspective of providers, the IMS Institute of Healthcare Informatics team points to six 
issues that all heath professionals should consider when prescribing apps to patients [4]: 
 
a) LEGAL: Does my institution endorse the app? Who is liable if the app is recommended?  
b) CHOICE/RATING: Which app is most relevant to my patient and how good is the app? 
c) INFRASTRUCTURE: How do I go about prescribing the app? 
d) REGULATIONS: Who regulates this app? Is it safe for me to recommend the app to patients? 
e) DATA PRIVACY/SECURITY: Can I be confident that my patient’s data is stored in a HIPAA 
complaint manner? 
f) REIMBURSEMENT: If the app is paid then will my patients pay for it or can they be 

























Figure 3: mHealth apps on the patient journey 
Source: Created from the IMS Institute for Healthcare Informatics’ 2013 
report “Patient Apps for Improved Healthcare.” 
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As healthcare providers, dietitians must also consider the above six issues when prescribing or assigning 
mHealth apps to their clients.  
 
Currently, the Academy of Nutrition and Dietetics, the largest organization for dietetic 
professionals, has not issued an official position paper for the use of mHealth apps to aid users/patients. 
Generally, the organization appears supportive towards dietitians using mHealth apps as supplemental 
tools for counseling patients. The Academy’s website features reviews for three nutrition-related app 
types including weight loss, diabetes and eating gluten-free [7]. Additionally, the Academy spotlights 
entrepreneurial dietitians that publish books reviewing apps available for purchase. Case in point: 
Catherine Frederico, MS, RD, LDN’s book “An App a Day” is available for purchase on her website 
and while it offers a good jumping point for finding “credible” apps, a book is not an ideal app delivery 
method since the mHealth app landscape is constantly changing. Still other dietitians like Elle Penner, 
MPH, RD (the MyFitnessPal dietitian) participate directly in the mHealth field by lending expertise to 
help developers create new app features.  
 
In sum, the current landscape of mHealth app is relatively new and biodiverse making it difficult 
to traverse: there are so many different mHealth apps out there how do we, as patients/users and 
providers, know which ones to choose? This questions along with other concerns voiced in this section 
must be addressed by healthcare providers, policy makers and app developers alike before mHealth apps 
can be a powerful and effective tool for patients and providers. As the mHealth app field matures, 
regulation is necessary to oversee their scope and ensure this balance: that the public is not unduly 
harmed and that innovation is not stifled. It is this very balance, which makes FDA regulation of 
mHealth apps controversial. 
 
 
IV. Food & Drug Administration (FDA) Policy: Regulation of Mobile Medical Apps 
 
 The Food and Drug Administration (FDA) asserts a public health responsibility to oversee the 
safety and effectiveness of medical devices, which includes mobile medical apps [8]. In September 
2013, the FDA passed its final guidance for mHealth apps, which focuses regulation on mHealth apps 
that pose a greater risk to patients/users if they do not work as intended [8,9]. mHealth apps will be 
regulated by the FDA using a risk-based approach wherein apps that pose a greater risk to patients/users 
must bear more administrative burden. The three tiers of regulation are [9, 10]: 
 
CLASS I “LOW RISK”: App is subjected to general controls but require no pre-
market submission before releasing. To have general controls in place the app developer 
must assure the FDA they will prevent adulteration and misbranding, register the app, 
notify prior to market release and keep records/reports for these activities. The FDA has 
the right to ban devices it finds risky and force companies to repair replace or refund 
consumers if the device is found unduly risky [11].  
 
CLASS II “MODERATE RISK”: App is subjected to special controls and requires 
submitting a notification document under section 501(k) of the Food Drug & Cosmetic 
Act (FD&CA). This document helps the app claim it is “substantially equivalent” to an 
existing app in class II and therefore does not need stringent regulation. Special controls 
means meeting general controls plus having: performance standards, post-market 
surveillance, patient registries, special labeling requirements, pre-market data 




CLASS III “HIGH RISK”: App is subjected to general controls and must get pre-
market approval from the FDA. Premarket approval means the FDA will conduct 
scientific and regulatory review to evaluate safety and effectiveness before market release 
[12].  
 
 mHealth apps that are considered “mobile medical 
apps” will meet the definition for a “medical device” in section 
201(h) of the FD&CA [9, 13,14]. An in-depth definition is 
provided in “Legal Lingo.” On the risk continuum, apps 
classified as class III are high risk because they’re meant to 
sustain or support human life while an app classified as class I 
may not be intended for this [12]. If a mHealth app is a 
medical device, it should and is regulated but what remains 
contentious are the many mHealth apps without FDA 
oversight.  
 
In order to decrease regulation burden, the FDA created 
a category for apps that meet criteria for “enforcement 
discretion.” This category is separate from the class I-III risk 
categories described above so if a mHealth app meets this 
special category it will be exempt from regulation altogether. 
A number of mHealth apps falling into the FDA’s 
“enforcement discretion” category are intended for use to in 
the diagnosis, cure, mitigation, treatment or prevention of 
diseases and conditions. These apps will not be reviewed by 
the FDA and include those that [9, 14]: 
 
1. Help patients self-manage disease or conditions without providing specific treatment or 
treatment suggestions. 
2. Provide patients with simple tools to organize and track health info.  
3. Provide easy access to info related to patient’s health conditions or treatments. 
4. Help patients document, show or communicate potential medical conditions to health care 
providers.  
5. Automate simple tasks for health care providers (e.g. BMI calculator).  
6. Enable patients or providers to interact with Personal Health Record or electronic health records 
(EHR) systems.  
 
The first category for enforcement discretion is particularly pertinent to dietitians since these 
apps can “provide or facilitate supplemental clinical care, by coaching or promoting to help patients 
manage their health in their daily environment [10].” Patients can potentially receive coaching for 
cardiovascular disease, high blood pressure, diabetes, overweight/obesity, forming healthy eating habits 
and much more. This could breach on a dietitian’s scope of practice if non-registered dietitians are used 
as coaches [15]. While these mHealth apps are still treated a supplemental to professional clinical care 
advice, patients are prompted to wave their rights to litigate when they use these apps. Given the 
complexity of chronic diseases aforementioned, are these apps completely low risk? If not, what steps 
must be in place to protect patients/users? How will dietitians deal with the issue of mHealth apps that 
cross into their scope of practice? Will the relationship be supplementary, complementary or 
competitive? To answer these questions and many more we must explore gaps in the way that mHealth 
Legal Lingo: “Medical Device” 
 
"An instrument, apparatus, implement, 
machine, contrivance, implant, in vitro reagent, 
or other similar or related article, including a 
component part, or accessory which is:  
a) Recognized in the official National 
Formulary or the United States 
Pharmacopoeia, or any supplement to 
them,  
b) Intended for use in the diagnosis of 
disease or other conditions, or in the cure, 
mitigation, treatment, or prevention of 
disease, in man or other animals, or  
c) Intended to affect the structure or any 
function of the body of man or other 
animals, and which does not achieve its 
primary intended purposes through 
chemical action within or on the body of 
man or other animals and which is not 
dependent upon being metabolized for the 
achievement of any of its primary intended 
purposes." 
 




apps are currently created, distributed and used. These gaps will be classified into five areas: technical, 
data privacy, efficacy, legality and scope of practice. 
 
 




As mHealth apps gain mass popularity, app developers must design features to reflect concerns for 
the user’s experience and data security. Users including patients and providers must demand that the 
following be addressed [16]:  
 
1) Connectivity: how well connected is the app to the Internet and will disconnection disrupt 
service? 
2) Data integrity: can electromagnetic interference with the phone corrupt data received and 
transmitted and what implications does it have? 
3) Data security: is the information safe from cyber-attack, malware, viruses, etc. and can data be 
traced to the user? 
4) Updating protocol/procedures: will the app require updates and security patches and how crucial 
are these things to make the app work safely for users? 
5) Display size/resolution: could this distort information and lead to riskier outcomes? 
6) User-friendliness: is the app designed for an intuitive user experience? Does the app have a clean 
and fun presentation? Does it quickly respond to users? 
 
While most of the solution remains in the court of app developers, dietitians and other healthcare 
providers can step up by offering their expertise to mHealth app development companies. This way 




As for data privacy, HIPAA considers “protected health information (PHI)” as health 
information whether oral or recorded by a health care provider, health plan, public health authority, life 
insurer, school of university or health care clearinghouse that relates to the past, present, future physical 
or mental health of any individual [17]. Information kept by these mobile medical apps does not meet 
the criteria of PHI because they are not created by the aforementioned entity but the type of data that 
apps keep can be similar to those recorded by these entities (e.g., blood glucose, blood pressure, 
identifying health information like names, DOB, addresses). Therefore, mHealth apps targeting users 
with chronic conditions (e.g., diabetes, heart disease) should be subjected to similar levels of 
confidentiality that HIPAA imposes on other entities. Yang et al. suggests that mHealth app companies 
be considered an entity for whose records would count as PHI. He asserts that this threat of privacy 
liability will incentivize these companies to adopt policies minimizing data breach [18]. Not all 
information might require this level of protection, so in order to understand what data does need 




In a study by Buljink et al, researchers claimed that mHealth apps lack evidence, which 
undermines quality and safety for users [19]. The researchers stated two studies in dermatology and 
microbiology that less than 35% of medical apps had medical experts involved. 86% of 111 pain 
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management apps did not have medical professional involvement. A pharmaceutical app was recalled 
because it provided a different disease-severity score than those from calculated with an official formula 
(no harm to patients to date). Additionally, there is conflict of interest if pharmaceutical companies 
come up with apps for providers.  
 
Buljink et al. suggests that we need to increase app safety by increasing transparency [19]. Given 
that the IMS Healthcare Informatics team found only 23,682 (54%) out of 43,689 “Health & Fitness” 
apps had useful benefits, there should be a system to help providers and users/patients navigate the app 
maze [4]. Buljink et al. suggests peer reviewed systems for mobile medical apps so that providers can 
have tried and true apps to recommend to patients. Additionally, Buljink et al. suggested that all 
mHealth app developers should register their app in an international app registry and submit premarket 
notifications to accrediting bodies and medical experts who can establish safety and effectiveness. While 
this is a prudent method the researchers conceded it would decelerate innovation in this industry.  
 
Cortez et al. believes that FDA should regulate apps that incorporate clinical-decision support. 
They would like to see a post-market surveillance system since apps are likely to evolve in the direction 
of offering medical advice or suggestions [10]. Currently, there are apps in development and in the 
market that offers nutrition advice to users. Having a post-market surveillance system in the works will 
be a way to monitor if the FDA needs to up the ante with their regulation. Given the newness of the 




As previously discussed, mHealth apps are beneficial to healthcare but not all apps meeting the 
“discretionary enforcement” category are necessarily low risk [10, 16]. For example, an app coaching 
users with diabetes may offer food suggestions based on the user’s entered blood glucose. Who is to 
blame if this suggestion adversely affects the user’s blood glucose (e.g., exacerbates hyperglycemia or 
induces hypoglycemia)? The FDA’s guidance for regulating mHealth apps is focused on the user’s risk 
but what about risk to the health care providers who recommend the app to their patients? Previously, 
the IMS Healthcare Informatics Team discussed legality as key provider concern and now it is time to 
address it. 
 
In a Health Affairs policy brief, Yang et al. discusses the issue of licensure and how it can affect 
providers using mHealth apps to triage patients in other states [18]. He explains that using mHealth apps 
to communicate with other providers poses a cross-jurisdictional practice of medicine. Thus far, the 
health field’s regulation is left to state government with fifty US states having their own licensing 
requirements—this is true in medicine and in dietetics. For the purposes of delivering health diagnoses, 
medical advice, coaching or counseling would mHealth companies need to follow the model of 
telemedicine and telehealth services? Doing so would require they register providers (e.g., those 
interacting with users) in an interstate practice database and offer specialty licensing or certificates. Both 
these measures require more time and money for both mHealth app developers and the providers. 
 
Additionally, Yang et al. suggests that mHealth apps are a new opportunity for litigation in the 
form of malpractice lawsuits. In the traditional sense, malpractice lawsuits occur when providers “owed 
a duty of care to a patient and deviated from it, with the patient being injured as a result” [18]. But, what 
happens if the provider’s breach in standard of care is the result of receiving faulty information from the 
mHealth app? While Yang et al. gave no good solutions to this issue it is precisely why providers may 





Scope of Practice 
 
The Academy of Nutrition and Dietetics should also be more involved in regards to mHealth 
apps that infringe on the scope of dietitians. Not all users need the highly specialized health services of 
dietitians, so there should be a way to parse users at low-risk versus high-risk when it comes to receiving 
nutrition services. An example of such a system is the Women Infants and Children (WIC) program 
where mothers at “high-risk” for nutrition issues see a registered dietitian while nutritionists see mothers 
at “low-risk” for nutrition issues. 
 
 
VI. Recommendations for Stakeholders 
 
Given the gaps in current regulation and oversight of mHealth apps more must be done to ensure 




 Conduct studies that evaluate efficacy of mHealth apps relevant to their health claims. 
 Identify the populations that would benefit most from the use of various types or functionalities 
of mHealth apps.  
 
Healthcare Industry (Health Insurance and Healthcare Organizations) 
 Come up with a system to rank mHealth apps in terms of efficacy. 
 Create a dynamic database accessible and updated by practitioners who can play a contributory 
role in rating mHealth apps in their practice.  
 Design a protocol (a standardized method) to prescribe mHealth apps to patients who may 
benefit from its use. 
 Figure out how mHealth apps could be reimbursed by health insurance companies.  




 The FDA should re-evaluate their stance on “discretionary enforcement” particularly when it 
comes to mHealth apps that “help patients self-manage disease or conditions without providing 
specific treatment or treatment suggestions.” 
 The Federal Trade Commission (FTC) should evaluate false claims and gimmicks that appear on 
the mHealth app store. 
 mHealth app companies should be a stipulated entity under HIPAA and health information kept 
by these companies should be PHI. The Department of Health and Human Services (HHS) will 
then have a crucial role in monitoring HIPAA violations by mHealth apps. 
 
Health Organizations 
 Practitioner organizations like the Academy of Nutrition and Dietetics, the American Medical 
Association, the American Nurses Association, etc. should come up with their own position 
statement for the role of mHealth apps in their respective field. 
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 Practitioner organizations should collaborate with health industry (e.g. health insurance 
companies and healthcare organizations) to draft guidance for providers on how to use mHealth 
apps in their practice. 
 
mHealth App Companies 
 Have software developers address the five technical issues mentioned above (connectivity, data 
integrity, data security, updating protocol/procedures, display size/resolution). 
 Consult pertinent healthcare providers such as physicians, dietitians, nurses, physicians 
assistants, etc. in the design and improvement of mHealth apps. 
 Consult pertinent experts in the evaluation of app safety and efficacy. 
Dietitian/Nutrition Professionals & Healthcare Providers 
 Consult for mHealth app companies to guide design or improve features of mHealth apps. 
 Contribute to mHealth app reviews to patients and providers surface the most safe and 
efficacious mHealth apps. 
 Educate patients on which mHealth apps to purchase/use and how to use those apps effectively 
for their condition/goals. 
 Demand assurance from app developers that the products ensure security and privacy of patient 
data. 
 Demand that health insurance companies cover efficacious mHealth apps in their health 
insurance plans.  
 
Users/Patients 
 Contribute to mHealth app reviews to patients and providers surface the most safe and effective 
mHealth apps. 
 Demand assurance from app developers that the products ensure security and privacy of patient 
data. 
 Demand that health insurance companies cover efficacious mHealth apps in their health 





The expansion of mHealth apps into the healthcare field is a challenging thought exercise that is 
soon to become a reality. The best-case scenario for this reality is that mHealth apps will help patients 
achieve and providers provide cheaper, more optimal healthcare. The FDA, or any one entity alone, 
cannot be counted on the guarantee that this vision is realized. Rather, all stakeholders described above 
must work together to build the infrastructures and enact the policies necessary to guide mHealth app 
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